// App-Quantinova.ai

3551 : Discovery of orally bioavailable novel Mcl-1 inhibitors that exhibit selective anti-proliferative activity in Mcl-1 sensitive cancer cell lines

Researchers

Presenter

  • Taekyu Lee

Principal Investigators

  • Zhiguo Bian

  • Johannes Belmar

  • Subrata Shaw

  • James C. Tarr

  • Bin Zhao

  • Nick Pelz

  • DeMarco Camper

  • Craig M. Goodwin

  • Allison L. Arnold

  • John L. Sensintaffar

  • Carrie F. Browning

  • Olivia W. Rossanese

  • Edward T. Olejniczak

  • Stephen W. Fesik

Medical Centers

  • Vanderbilt University, Nashville, TN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Myeloid Cell Leukemia 1

  • B-cell lymphoma 2

  • B-cell lymphoma-extra large

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved